Giant Cell Tumor of the Extremity

刮除术 医学 骨巨细胞瘤 巨细胞 外科 巨细胞瘤 骨移植 病理
作者
Xiaohui Niu,Qing Zhang,Hao Lin,Yi Ding,Yuan Li,Hairong Xu,Weifeng Liu
出处
期刊:Journal of Bone and Joint Surgery, American Volume [Wolters Kluwer]
卷期号:94 (5): 461-467 被引量:188
标识
DOI:10.2106/jbjs.j.01922
摘要

Background: There are no recent reports of giant cell tumors of bone in a large series of Chinese people. The present study was designed to review the epidemiological characteristics and outcomes of surgical management in a large series of Chinese patients with giant cell tumor of an extremity, treated at a single institution. Methods: The records and images of 621 patients in whom a benign giant cell tumor in an extremity was treated between 1989 and 2009 were reviewed retrospectively. There were 359 male and 262 female patients. The mean age at diagnosis was 31.4 years (range, eleven to seventy-one years). Sixty-six percent of the giant cell tumors were localized around the knee. Surgical treatments primarily included curettage, extensive curettage, and resection. The median duration of follow-up was forty-nine months (range, eighteen to 256 months). Results: Giant cell tumor accounted for 13.7% of all primary bone tumors treated at our institution. Multivariate Cox regression analysis indicated that the only variable that contributed to recurrence-free survival was the type of surgical treatment. The local recurrence rate after extensive curettage was 8.6%, which was significantly lower than the 56.1% recurrence rate after curettage alone. Bone-grafting did not affect local tumor control after extensive curettage; the local recurrence rate was 11.1% if bone graft was used. Recurrent giant cell tumor can be treated by further curettage or resection, with acceptable re-recurrence rates of 6.7% and 9.3% respectively. The Musculoskeletal Tumor Society Score for patients treated with extensive curettage was 92.6%, which was significantly higher than that for patients treated with resection. Twenty-one (3.4%) of the 621 patients developed benign pulmonary metastasis, with a favorable outcome, and three patients presented with multifocal giant cell tumors. Conclusions: The incidence of giant cell tumor in the Chinese population may be higher than that in Western countries, and it has a male predilection. The results of the present study suggest that extensive curettage provides favorable local control and satisfactory functional outcomes. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
mly完成签到 ,获得积分10
刚刚
刚刚
月亮很亮完成签到,获得积分10
1秒前
luo发布了新的文献求助10
1秒前
LILI完成签到 ,获得积分10
1秒前
Ava应助wjf采纳,获得10
1秒前
务实元霜发布了新的文献求助10
1秒前
希望天下0贩的0应助qazx采纳,获得10
2秒前
辣条机会有限完成签到 ,获得积分10
2秒前
Lz发布了新的文献求助10
2秒前
3207781927发布了新的文献求助10
3秒前
石家豪完成签到,获得积分10
3秒前
lxq888完成签到,获得积分10
3秒前
dllz发布了新的文献求助10
4秒前
wanci应助科研通管家采纳,获得10
4秒前
4秒前
蓝天应助小明采纳,获得10
4秒前
123应助科研通管家采纳,获得10
4秒前
CFD应助科研通管家采纳,获得10
4秒前
danni发布了新的文献求助10
4秒前
huhutu发布了新的文献求助30
4秒前
无花果应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
我是老大应助科研通管家采纳,获得30
5秒前
5秒前
科大第一深情完成签到,获得积分10
6秒前
xingxing发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6520480
求助须知:如何正确求助?哪些是违规求助? 8313540
关于积分的说明 17781386
捐赠科研通 5622596
什么是DOI,文献DOI怎么找? 2927210
邀请新用户注册赠送积分活动 1904050
关于科研通互助平台的介绍 1764386